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Introduction
Humans are exposed to a variety of toxic 
chemicals and have access to a wide array 
of drugs, each of which has the potential to 
cause short- and long-term adverse effects, 
including lethality. From an environmental 
health perspective, it is important to find a 
strong connection between toxic substances 
and human disease susceptibility, thereby 
elucidating molecular mechanisms of toxicity.
Although animal models are currently 
the gold standard in evaluating risk and 
predicting adverse human health effects, they 
require considerable time and resources, and 
the use of animal models also raises ethical 
issues (Bissell et al. 2001; Greaves et al. 2004; 
Hebels et al. 2014; Kola and Landis 2004; 
Metushi and Uetrecht 2014; Suter et al. 
2011). For these reasons, several efforts have 
been made to minimize the use of animals 
in toxicology (http://www.alttox.org) and 
to develop robust in vitro models predic-
tive of toxicity in humans (Abbott 2005). 
A European initiative, the Registration, 
Evaluation, Authorization and Restriction 
of Chemicals (REACH) legislation, suggests 
the use of high-throughput “omics” tech-
nologies, such as genome-wide gene expres-
sion profiling, to find alternatives to animal 
testing. The REACH legislation states:
The Commission, Member States, industry and 
other stakeholders should continue to contribute 
to the promotion of alternative test methods on 
an international and national level including 
computer supported methodologies, in vitro 
methodologies, as appropriate, those based on 
toxicogenomics, and other relevant methodolo-
gies.” (http://www.reachonline.eu/REACH/EN/
REACH_EN/preamble1.html)
Multiple studies have used gene expres-
sion profiles to characterize toxicogenomic 
responses (Afshari et al. 2011; Chen et al. 
2012; Ellinger-Ziegelbauer et al. 2008; 
Nuwaysir et al. 1999). To confront chemical-
induced cellular stress, the biological system 
executes a transcriptional control over several 
signaling pathways (Grinberg et al. 2014; 
Kier et al. 2004). Because the liver plays a 
primordial role in detoxification and is 
a major site of frequent chemical-induced 
injuries, it has been extensively studied in 
toxicogenomics. Recently, the Japanese 
government and the pharmaceutical industry 
joined forces to create and make publicly 
available the largest toxicogenomic database 
to date: the Toxicogenomics Project–
Genomics Assisted Toxicity Evaluation 
system (TG-GATEs) (Uehara et al. 2010, 
2011). The TG-GATEs consortium tested 
~ 150 chemicals in different models, 
including primary human and rat hepatocytes 
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Background: Genome-wide expression profiling is increasingly being used to identify  transcriptional 
changes induced by drugs and environmental stressors. In this context, the Toxicogenomics Project–
Genomics Assisted Toxicity Evaluation system (TG-GATEs) project generated transcriptional 
profiles from rat liver samples and human/rat cultured primary  hepatocytes exposed to more than 
100 different chemicals.
oBjectives: To assess the capacity of the cell culture models to recapitulate pathways induced 
by chemicals in vivo, we leveraged the TG-GATEs data set to compare the early transcriptional 
responses observed in the liver of rats treated with a large set of chemicals with those of cultured rat 
and human primary hepatocytes challenged with the same compounds in vitro.
Methods: We developed a new pathway-based computational pipeline that efficiently combines 
gene set enrichment analysis (GSEA) using pathways from the Reactome database with biclustering 
to identify common modules of pathways that are modulated by several chemicals in vivo and 
in vitro across species.
results: We found that some chemicals induced conserved patterns of early transcriptional responses 
in in vitro and in vivo settings, and across human and rat genomes. These responses involved pathways 
of cell survival, inflammation, xenobiotic metabolism, oxidative stress, and apoptosis. Moreover, our 
results support the transforming growth factor beta receptor (TGF-βR) signaling pathway as a candi-
date biomarker associated with exposure to environmental toxicants in primary human hepatocytes.
conclusions: Our integrative analysis of toxicogenomics data provides a comprehensive overview 
of biochemical perturbations affected by a large panel of chemicals. Furthermore, we show that 
the early toxicological response occurring in animals is recapitulated in human and rat primary 
hepatocyte cultures at the molecular level, indicating that these models reproduce key pathways 
in response to chemical stress. These findings expand our understanding and interpretation of 
 toxicogenomics data from human hepatocytes exposed to environmental toxicants.
citation: El-Hachem N, Grossmann P, Blanchet-Cohen A, Bateman AR, Bouchard N, 
Archambault J, Aerts HJ, Haibe-Kains B. 2016. Characterization of conserved toxicogenomic 
responses in chemically exposed hepatocytes across species and platforms. Environ Health Perspect 
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as well as rat liver and kidney in vivo models 
(Uehara et al. 2010, 2011). The experimental 
design and gene expression profiles were 
made publicly available through the EBI 
ArrayExpress database (http://www.ebi.ac.uk/
arrayexpress/) (Brazma et al. 2003). Different 
studies used this large toxicogenomic data 
set to identify predictive biomarkers of 
hepatocarcinogenicity (Caiment et al. 2014; 
Yamada et al. 2013), phospholipidosis 
(Hirode et al. 2008b), and coagulopathy 
(Hirode et al. 2008a). However, despite the 
availability of these valuable data, one of the 
main challenges of toxicogenomics is that it 
remains unclear whether animal studies can 
be efficiently replaced by in vitro testing to 
identify key biological pathways induced by 
 hepatotoxic chemicals.
In this study, we performed a large-scale 
comparative analysis of the TG-GATEs data 
from rat liver samples (referred to as RLV) 
and from cultured rat and human primary 
hepatocytes (referred to as PRH and PHH, 
respectively) in order to a) identify conserved 
transcriptional responses induced by chemi-
cals across species and between in vitro and 
in vivo systems, and b) characterize the early 
response pathways linked to toxicity in both 
rat in vivo and rat/human in vitro experi-
ments. Building upon the recent study by 
Iskar et al. (2013), which showed that certain 
drugs affected modules of coexpressed genes 
conserved across a small set of three human 
cancer cell lines and rat liver samples, we 
developed a new pathway-based approach 
that combines gene set enrichment analysis 
(GSEA) and biclustering to efficiently inte-
grate large-scale toxicogenomic data across 
different species. Our analysis showed that 
chemicals affect a set of conserved pathways 
linked to chemical-induced toxicity across 
species and experimental platforms.
Materials and Methods
The overall design of our analysis is presented 
in Figure 1. The three experimental settings 
that we investigated in TG-GATEs were 
rat liver in vivo and rat and human primary 
hepatocyte in vitro and are referred to as 
RLV, PRH, and PHH, respectively.
Microarray retrieval and preparation. 
Rat liver and primary rat and human hepa-
tocyte microarray data files were downloaded 
from ArrayExpress (https://www.ebi.ac.uk/
arrayexpress/). The three studies with the 
accessions E-MTAB-799, E-MTAB-798, 
and E-MTAB-797 contain toxicogenomic 
data for RLV, PRH, and PHH experiments, 
respectively, for > 100 chemical compounds 
(Figure 1A). PHH and PRH were treated 
with each compound in duplicate, using three 
doses (low, middle, and high doses) for three 
different lengths of time (2, 8, and 24 hr; 
Figure 1A). Rat liver samples were obtained 
from animals treated with each compound in 
triplicate and sacrificed at 3, 6, 9, and 24 hr 
after dosing (Figure 1A). The highest dose 
refers to the maximally tolerated dose. Each 
compound is associated with a corresponding 
vehicle control for all experimental conditions.
All CEL files (Affymetrix data format that 
contains the raw intensity values for both 
perfect match and mismatch probes) were 
checked for duplicated names and inconsis-
tencies. It was noted that data were missing 
from human hepatocytes treated with the 
low dose of 71 chemicals; these 71 chemi-
cals were nevertheless retained and analyzed 
along with the other 48 chemicals. In total, 
the transcriptional effects of 119 chemicals on 
human hepatocytes were obtained from 2,004 
microarrays (Affymetrix GeneChip Human 
Genome U133 Plus 2.0 platform; Affymetrix, 
Inc.). Similarly, the effects of 129 chemicals 
on rat liver samples and rat hepatocytes were 
obtained from 6,192 and 3,096 microarrays, 
Figure 1. Analysis workflow for the TG-GATEs data set. (A) Overview of the TG-GATEs experimental 
design. TG-GATEs includes rat liver in vivo (RLV), rat hepatocyte in vitro (PRH), and human hepatocyte 
in vitro (PHH) experiments to test transcriptional responses for > 100 chemical compounds. Samples have 
been treated with three doses of chemical alongside a control group, and gene expression was measured 
repeatedly within 24 hr (h) as shown. (B) Pathway-based analysis pipeline. A comparative analysis of the 
three TG-GATEs experiments was conducted by investigating chemical-induced pathways in RLV, PRH, 
and PHH. For each chemical, a linear regression model was fitted for every gene to assess the effects of 
the chemical on gene expression, taking into account the treatment period and the dose. Based on these 
association models, genes were ranked to perform a gene set enrichment analysis (GSEA) on common 
Reactome pathways. From the enrichment results, transcriptional modules conserved across experi-
mental settings (RLV, PRH, and PHH) were identified by biclustering.
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respectively (Affymetrix GeneChip Rat 
Genome 230_2.0;  Affymetr ix ,  Inc . ) 
(Figure 1B). All data sets, including kidney 
samples in E-MTAB-799 and the repeated 
dose study (accession E-MTAB-800), were 
downloaded and curated on the fly through 
our fully automated pipeline. Documented 
code is available on GitHub (https://github.
com/bhklab/TGGATES).
Gene expression data. Gene expres-
sion data were normalized with the robust 
multiarray average (RMA) algorithm 
(Irizarry et al. 2003) using the Bioconductor 
BufferedMatrixMethods package (version 
1.30.0) (Gautier et al. 2004). Probes 
were mapped to Entrez Gene IDs using 
the Bioconductor annotation packages 
hgu133plus2.db (v3.0.0; Carlson 2015a) 
and rat2302.db (v3.0.0; Carlson 2015b) 
for human and rat, respectively. In case of 
multiple probes mapped to the same Entrez 
Gene ID, we used the Bioconductor genefu 
package (v1.15.0) to select the most variant 
probe set for each gene. This procedure 
yielded 20,590 and 14,462 unique genes for 
human and rat, respectively.
Pathway collections. Every gene in the 
curated microarray experiments in TG-GATEs 
was assigned to pathways described in the 
Reactome database (Croft et al. 2014) using 
the Bioconductor BiomaRt package (v2.22.0), 
for both rat and human genes present in the 
microarray platform. Pathway collection was 
performed on 5 March 2014. We subsequently 
selected the common pathways for rat and 
human, and we retained only gene sets of sizes 
between 15 and 500 genes, which resulted 
in 419 common Reactome pathways for the 
GSEA analysis (see Supplemental Material, 
Figure S1). For reproducibility, all curated 
pathways were stored in gmt files online 
(https://github.com/bhklab/TGGATES).
Gene–chemical associations. Gene ranking 
was based on gene–chemical associations, 
which were identified by fitting linear models 
to estimate the effects of chemical dosage on 
gene expression controlled by treatment time 
and interaction between dosage and time. For 
each pair of gene i and chemical j, we used 
the following model:
 Gi = β0 + β1Dj + β2Tj + β3DjTj, [1]
where Gi denotes the expression value of 
gene i; Dj is the dose of chemical j; Tj is the 
treatment time for chemical j; β0 is the inter-
cept; and β1, β2, and β3 are the regression 
coefficients for the chemical dosage, treat-
ment time, and interaction term of dose and 
treatment, respectively. The strength of the 
linear gene–chemical association is given 
by β1, and its significance (p) is computed 
using Student’s t-test as provided by the lm() 
function in R (R Core Team 2013).
Pathway–chemical associations. Pathways 
that were significantly perturbed by each 
chemical were identified using the java imple-
mentation of GSEA (v2.0.14) (Subramanian 
et al. 2005) provided by the Broad Institute. 
For each chemical, we first ranked all genes 
with respect to the signed significance of 
their gene–chemical association: that is, 
sign(β1) × –log10(p), as in Equation 1. We 
then used each chemical-specific ranked list of 
genes to perform a preranked GSEA to calculate 
normalized enrichment scores (NESs) for all 
common pathways between human and rat. 
The higher the absolute value of the NES, the 
more enriched was the corresponding pathway 
in genes whose expression was significantly 
perturbed by the chemical of interest. We 
repeated this process for each chemical and 
created an “enrichment matrix” with pathway 
enrichment scores (rows) and chemicals 
(columns) for each data set (Figure 1B).
Conserved transcriptional modules. One 
hundred and fifteen chemical compounds 
were common to all three experimental 
settings (Figure 1B; see also Supplemental 
Material, “Common list of chemicals: One 
hundred and fifteen common chemicals 
analyzed in the TG-GATEs project”). For 
each of these data sets, we applied a biclus-
tering method: that is, we applied the itera-
tive signature algorithm (ISA) (Bergmann 
et al. 2003) implemented in the isa2 package 
(v0.3.3) (Csárdi et al. 2010) in R (R Core 
Team 2013) to the enrichment matrix to 
simultaneously identify similar biochemical-
induced transcriptional response patterns. 
The ISA algorithm runs with all combinations 
of threshold values on rows and columns, 
which has been described in detail on the 
TG-GATEs companion website (https://
www.pmgenomics.ca/bhklab/pubs/tggates). 
Similarly to Iskar et al. (2013), we merged 
modules with similar sets of pathways using 
the isa.unique() function in the isa2 package 
to filter redundant modules using a correlation 
limit of 0.5 to determine redundant biclus-
ters. Lastly, modules sharing common sets of 
pathways and common chemicals across the 
different data sets—namely RLV, PRH, and 
PHH (inter–data set similarity)—were iden-
tified using a one-sided hypergeometric test 
(p < 0.001); this technique is referred to as the 
reciprocal best-hit approach (Iskar et al. 2013).
Reproducible research. To ensure full 
reproducibility, this work complied with the 
guidelines proposed by Robert Gentleman 
(Gentleman 2005) in terms of the availability 
of the code and the reproducibility of results 
and figures. The procedure to properly set 
up the software environment and run our 
analysis pipeline is provided in Supplemental 
Material, “Reproducibility of analysis.” The 
analysis code is also publicly available at 
https://github.com/bhklab/TGGATES.
Results
The approach we used to investigate the 
pathways altered by chemical perturbations 
leverages the transcriptional profiling data 
available in TG-GATEs for RLV, PRH, 
and PHH, as summarized in Figure 1A. We 
analyzed each of these three data sets separately 
and compared the results from the in vitro–
treated hepatocytes (PRH and PHH) with 
those from the livers of treated rats (RLV) 
because this animal model is considered 
to be the gold standard in toxicity studies. 
Preprocessing of these gene expression data 
sets yielded sets of 20,590 and 14,460 unique 
genes from the human and rat microarray 
platforms, respectively, that were kept for 
subsequent analysis. The association between 
gene expression and the 115 chemicals that 
were common to the three TG-GATEs experi-
mental settings (PRH, PHH, and RLV) was 
then investigated at the pathway level using 
the preranked version of GSEA (Subramanian 
et al. 2005). A total of 419 pathways that 
were common to both rat and human were 
queried from the Reactome database to 
identify pathways that were modulated upon 
chemical perturbation (see Supplemental 
Material, Figure S1). Matrices containing the 
enrichment scores of each pathway perturbed 
by each chemical were then analyzed using 
an unsupervised biclustering technique, ISA 
(Bergmann et al. 2003), to define functional 
modules (i.e., clusters of pathways) specifically 
associated with diverse chemical treatments. 
Each module was given a summary name, that 
is, a Reactome parent term that best recapitu-
lated the pathways enriched in the module (see 
Supplemental Material, Table S1).
Conservation of transcriptional modules 
across experimental settings. Rat liver 
in vivo treated with a single dose. Twenty-
four nonredundant modules were identi-
fied using the aforementioned ISA analysis 
(p < 0.001). These modules were enriched 
for the following biological pathways: 
neuronal system; hemostasis; cell cycle 
checkpoints; DNA repair; mitosis; lysosome 
disorders; innate immune system; NOTCH, 
transforming growth factor beta receptor 
(TGF-βR)/SMAD, and phosphoinositide 
3-kinase/protein kinase B (PI3K/AKT)
signaling cascades; lipid metabolism; and 
mitochondrion-dependent processes. The 
summary names of all modules are provided 
in Supplemental Material, Table S1.
Primary rat hepatocytes versus rat 
liver in vivo. The ISA algorithm detected 
18 modules in PRH. Interestingly, 17 modules 
overlapped with RLV using a reciprocal best-hit 
approach in which 2 modules were considered 
to be conserved if their Reactome pathways 
significantly overlapped (Iskar et al. 2013) 
(hypergeometric p < 0.001). Only 1 module 
related to cholesterol biosynthesis did not 
El-Hachem et al.
316 volume 124 | number 3 | March 2016 • Environmental Health Perspectives
overlap at the specified cutoff. Figure 2 shows 
in detail the number of nonredundant ISA 
modules in each data set and their  conservation 
across the experimental settings.
Primary human hepatocytes versus rat 
liver in vivo. ISA analysis resulted in the identi-
fication of 15 modules in PHH toxicogenomic 
data. Again, all but one (i.e., 14 modules) 
overlapped with RLV ( hypergeometric 
p < 0.001; Figure 2).
Overall, we identified 13 modules that 
were conserved across the three experimental 
setting data sets (RLV, PHH, and PRH) 
(see Supplemental Material, Table S1 and 
Figure S2). As a representative example, we 
show a conserved module in Figure 3. The 
module is enriched for components of the 
innate immune system, and the overlapping 
pathways are in the same order for RLV, 
PHH, and PRH. We extracted the union of 
the genes that were found to contribute to the 
enrichment score [referred to as “leading edge” 
(Subramanian et al. 2005)] of at least one 
pathway for all chemicals in the module. From 
this union, we obtained a list of common 
genes that were activated or repressed by 
chemical stress in RLV, PRH, and PHH. 
Heatmaps for all ISA settings, lists of hyper-
geometric p-values, and lists of leading edge 
genes are provided in separate Supplemental 
Material, Zip files S2, S3, and S4.
Enrichment for hepatocarcinogens. The 
approach described above identified 13 
modules associated with the early response 
of hepatocytes to diverse chemicals that are 
conserved in vivo, in vitro, and between rat 
and human. To test whether some modules 
were significantly associated with the hepato-
cyte response to known hepatocarcinogens, 
we investigated 25 previously validated rat 
hepatocarcinogens (Yamada et al. 2013) 
present among the 115 chemicals investigated 
in our study (see Supplemental Material, 
“Common list of chemicals: One hundred 
and fifteen common chemicals analyzed in the 
TG-GATEs project”). Specifically, these hepa-
tocarcinogens were significantly enriched in 
the NOTCH and TGF-βR/SMAD signaling 
modules in PHH (hypergeometric p < 0.05), 
but not in PRH or RLV. The TGF-βR/
SMAD signaling module (Figure 4A) in 
PHH was enriched for known environmental 
toxicants and carcinogens (e.g., ethionine, 
thioacetamide, coumarin, ethanol, 2-acetami-
dofluorene, N-nitrosodiethylamine). None of 
these modules was enriched for hepatocarcino-
gens in RLV, and this was only the case for 
the PI3K/AKT module in PRH (p = 0.049; 
see Supplemental Material, Zip file S3). The 
known rat hepatocarcinogens were also signifi-
cantly associated with the neuronal system/G 
protein-coupled receptors (GPCRs) module in 
both RLV and PHH, but not in PRH, likely 
reflecting the pleiotropic roles that GPCRs 
play in many cellular processes, including 
chemical carcinogenesis (see Supplemental 
Material, Zip files S2 and S3).
As a control experiment, we selected 12 
noncarcinogenic compounds (see Supplemental 
Material, “Common list of chemicals: One 
hundred and fifteen common chemicals 
analyzed in the TG-GATEs project”) and 
determined whether they were significantly 
associated with any of the modules in RLV, 
PRH, and PHH. As anticipated, no enrich-
ment was observed, particularly for those 
modules enriched for known hepatocarcino-
gens in PHH. As an additional control, we 
ascertained that the NOTCH and TGF-βR/
SMAD modules were indeed enriched in 
cancer-related pathways by showing that the 
20 pathways containing the word “cancer” in 
the Reactome common data set (out of 419 
pathways in total) were in fact enriched in 
those modules (hypergeometric p < 0.001). 
This enrichment did not occur for any of the 
remaining modules without cancer terms. 
Collectively, the results presented above 
support that primary human hepatocytes can 
detect potential environmental chemical carcin-
ogens (Figure 4A). By extension, we inferred 
that the other modules were also enriched in 
pathways pertinent to chemical exposure.
Activation of the peroxisome proliferator 
activated–receptor alpha. Because some peroxi-
some proliferator activated–receptor alpha 
(PPARα) activators are known to induce 
hepatocarcinogenesis in rodent liver, we 
investigated whether PPARα activators (e.g., 
benziodarone, benzbromarone, fenofibrate, 
clofibrate, ibuprofen, WY-14643, gemfibrozil) 
were randomly distributed across modules in 
RLV, PHH, and PRH. Interestingly, none of 
the modules in PHH or PRH was enriched 
for those drugs; however, we found that a 
module unique to RLV was significantly asso-
ciated with the regulation of lipid metabolism 
by PPARα and was enriched for those drugs 
(p = 0.014). Other potential PPARα inducers 
were found in this module, including nonste-
roidal anti-inflammatory (NSAIDs) and anti-
tuberculosis drugs (Figure 4B).
A recent study (Grinberg et al. 2014) 
showed that numerous compounds from 
TG-GATEs cause “stereotypical” transcrip-
tional responses in PHH. This term is used to 
describe a response wherein a cytotoxic concen-
tration of numerous compounds causes a 
consensus expression response regardless of the 
chemical class of compound. For each module, 
we assessed the significance of the overlap 
between all leading edge genes, which we gener-
ated from the biclustering in PHH, and the 
genes deregulated by at least 20 compounds 
in the study by Grinberg et al. (2014). We 
demonstrated that stereotypical clusters of 
genes involved in liver metabolic functions 
and cell proliferation were enriched in two 
modules from PHH, mainly those associated 
with normal liver function and DNA synthesis. 
Furthermore, to ascertain that our observa-
tions from PHH were not simply experimental 
artifacts due to in vitro conditions, we selected 
liver cirrhosis as a case study and tested the 
enrichment for genes associated exclusively with 
liver cirrhosis in PHH (Grinberg et al. 2014). 
Interestingly, the TGF-βR signaling module 
in PHH (module 6) was significantly enriched 
for genes linked to liver cirrhosis in addition 
to being induced by known hepatocarcinogens 
and environmental toxicants (Figure 4B).
Finally, we demonstrated the similarity 
of the distributions of genes perturbed by rat 
hepatocarcinogens and nonhepatocarcinogens 
(see Supplemental Material, Figure S2).
Discussion
We tested the extent to which transcriptional 
responses associated with liver toxicity can 
be recapitulated across human and rat and 
between in vivo and in vitro settings. To do 
so, we exploited toxicogenomic information 
generated by the TG-GATEs project from 
liver samples of rats treated with different 
chemicals and from rat/human hepatocytes 
exposed to the same compounds in vitro. To 
date, several studies have used TG-GATEs 
to build predictors of relevant toxicological 
Figure 2. The number of non-redundant transcrip-
tional modules and proportions identified for each 
and across all experimental settings in TG-GATEs. 
Each bar corresponds to an experimental setting 
in TG-GATEs (RLV, PRH, PHH) and contains the 
number of modules found to be unique for the 
experiment (blue) or shows a corresponding 
module in another experiment (see color legend: 
green for conserved, purple for conserved in RLV 
vs. PHH, orange for conserved in PHH vs. PRH, 
yellow for conserved in RLV vs. PRH). Although 
only a few modules were detected in only one or 
two settings, most modules showed significantly 
high overlap in terms of pathway enrichment 
across all settings (hypergeometric p < 0.001).
0%
25%
50%
75%
100%
PHH
13
2
2
4
4 5
1
1
13 13
PRH RLV
Pr
op
or
tio
n 
of
 m
od
ul
es
Modules
Conserved
PHH vs. RLV
PRH vs. PHH
RLV vs. PRH
Unique
Toxicogenomics across species and platforms
Environmental Health Perspectives • volume 124 | number 3 | March 2016 317
Figure 3. Conservation of modules across in vitro and in vivo settings based on Reactome pathways. This example summarizes a conserved module between 
RLV, PRH, and PHH, shown as heatmaps and keeping overlapping pathways colored with respect to their enrichment scores: up-regulated pathways are shown 
in blue, and down-regulated pathways are shown in green. The three heatmaps correspond to a conserved module associated with the innate immune system 
(mod2 in RLV, mod15 in PHH, and mod10 in PRH). The leading edge genes from common pathways that are activated or repressed by chemicals are shown under 
the heatmap with known oncogenes colored in red. (For more details, see Supplemental Material, Zip files S2 and S4.)
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endpoints. For example, Zhang et al. recently 
used these data to build a predictive gene 
signature for both hepatotoxicity and nephro-
toxicity (Zhang et al. 2014). Interestingly, 
Zhang et al. (2014) revealed the impor-
tance of early response genes in triggering 
 toxicity- associated signaling networks, as high-
lighted by the high predictive power of the 
signature derived from a treatment period of 
less than 24 hr.
To our knowledge, our study is the 
first analysis of the TG-GATEs data 
comparing functional changes—in the form 
of transcriptional responses—induced by a 
large panel of chemicals in vivo (rat liver), 
in vitro (cultured hepatocytes), and across 
species (human vs. rat). A major feature of 
our approach is the fact that it relied on a 
pathway enrichment analysis, thereby 
allowing comparisons to be made between 
species without the need to rely on a limited 
subset of orthologous genes. In this context, 
it is worth contrasting our findings with 
those of Iskar et al. (2013), who identified, 
solely on the basis of orthologous genes, 
transcriptional modules that were conserved 
between rat liver (Natsoulis et al. 2008) 
and three human cancer cell lines from the 
Connectivity Map (CMap) (Lamb et al. 
2006). The findings of Iskar et al. (2013) 
revealed that 15% of the chemical-induced 
modules were conserved across cell lines and 
species. However, this approach was limited 
to 8,962 genes in CMap, which corresponded 
to only 3,618 orthologous genes available for 
the rat liver experiments. To overcome this 
limitation, by focusing on common pathways 
between species, our approach enabled a 
full exploration of the TG-GATEs data sets 
Figure 4. Characterization of putative biomarkers within chemical-induced modules. (A) Heatmap representing a module in PHH (mod6), associated with 
transforming growth factor beta receptor signalling, that can be considered as a candidate biomarker in humans for environmental exposure to known 
toxicants. Diverse rat hepatocarcinogens were enriched in this module. (B) Heatmap representing a module in RLV (mod5) that was relevant to toxicity mode of 
action and is enriched for a class of lipid-lowering drugs known as fibrates. These drugs are rat hepatocarcinogens and activate the peroxisome proliferation-
activated receptor alpha (PPARα). Green, down-regulation; blue, up-regulation. Drugs that activate PPAR pathways include nonsteroidal anti-inflammatory and 
antituberculosis drugs. All statistical details and genes contributing to these pathways are in Supplemental Material, Zip file S4.
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and allowed the identification of functional 
pathways altered by chemical treatments in 
both rat and human.
Our results indicated that the response of 
hepatocytes to chemical insults is analogous 
in vitro, in vivo, and across human and rat 
in that it involves a conserved set of cellular 
pathways. Specifically, we identified 13 
highly conserved modules representative of 
the early response of hepatocytes to chemical 
exposure. Two of those modules are enriched 
in key signalling pathways associated with 
cancer, namely the TGF-βR superfamily 
module (TGF-βR–mod17 in RLV) and the 
NOTCH signaling module (NOTCH–mod6 
in RLV). Given the roles that the TGF-βR 
and NOTCH pathways play in response 
to early toxicity (Zhang et al. 2014) and in 
maintaining normal liver function (Morell and 
Strazzabosco 2014), respectively, it was not 
surprising that these modules were enriched for 
known rat hepatocarcinogens, including envi-
ronmental toxicants. What is more puzzling, 
given our results, is the fact that these two 
pathways are significantly associated with hepa-
tocarcinogens only in humans and not in rats. 
This disparity may reflect a key difference in 
how both species handle these chemicals. That 
the responses of rats and humans may differ 
for some chemicals is further supported by our 
finding that the PPARα agonists clofibrate, 
fenofibrate, gemfibrozil, benziodarone, and 
benzbromarone up-regulate pathways associ-
ated with PPARα activation only in rat liver, 
thus providing a potential mechanism under-
lying the hepatocarcinogenicity of these drugs 
in rats but not in humans (Lai 2004).
Several lines of evidence suggest that 
the modules identified in the present study 
are relevant to how hepatocytes respond to 
chemicals. For example, one of the modules 
we identified, the innate immune system 
(mod2 in RLV), was enriched in proinflam-
matory Toll-like receptor signaling pathways, 
which were shown by Huang et al. to be 
good predictors of drug-induced liver injury 
(Huang et al. 2010). Our results are also 
consistent with those reported in comparative 
studies by Doktorova et al., who assessed the 
transcriptional profiles of toxicants for rat liver 
and a panel of in vitro models (Doktorova 
et al. 2012, 2013). Those studies assigned 
deregulated genes by performing in vivo/
in vitro comparison. Moreover, we found that 
pathways associated with G protein-coupled 
receptors (GPCRs) and the neuronal system 
were consistently affected by a variety of 
chemicals. Of particular relevance is the fact 
that some chemicals found in this conserved 
module (neuronal system–mod8 in RLV) can 
cause the potentially lethal long QT syndrome 
(delayed repolarization of the heart) by 
perturbing heart conductance. For example, 
ciprofloxacin, haloperidol, thioridazine, 
quinidine, and amiodarone are well known to 
prolong the QT interval and to cause torsades 
de pointes, a deadly form of arrhythmia (Fazio 
et al. 2013). This module was also enriched 
for known rat hepatocarcinogens in RLV and 
PHH but not in PRH, a finding that may 
relate to the fact that ion channels, in addition 
to being involved in long QT syndrome, can 
also play a role in carcinogenesis (Babcock 
and Li 2013). However, this observation 
might not be specific to a particular class of 
compounds because the Reactome pathways 
related to the neuronal system contain a 
large number of genes (> 500). Our findings 
also suggest that some chemicals modulate 
pathways associated with vitamin metabolism 
(metabolism of vitamins and cofactors–mod3 
in RLV) in hepatocytes, in particular those 
associated with the inherited metabolic disor-
ders methylmalonic aciduria and homocys-
tinuria. Surprisingly, the scientific literature 
contains only a few reports pertaining to the 
association between chemical-induced liver 
injury and vitamins. Among the studies that 
we found relevant to this work, one describes 
an association between high levels of circu-
lating cobalamin (vitamin B12) and several 
serious liver diseases (Ermens et al. 2003), 
and another highlights the role of vitamin 
B12 metabolism in methylmalonic aciduria, a 
disorder that can lead to severe liver injury and 
necessitate, in some cases, liver transplantation 
(Hansen and Horslen 2008). Given the strong 
association between vitamin metabolism and 
early drug exposure that has been revealed in 
our study, it may be of interest to explore this 
understudied area of research in greater depth.
Furthermore, we confirmed the biological 
relevance of our biclusters against findings from 
a recent study (Grinberg et al. 2014). Indeed, 
we showed that our modules recapitulated 
stereotypical response to chemicals as well as 
compound-specific perturbations. Moreover, 
we found evidence that the TGF-βR signaling 
module in PHH could act as a potential 
biomarker of chemical injury that may lead to 
liver cirrhosis in addition to being enriched for 
known hepatocarcinogens.
It is worth noting that our new bioin-
formatics pipeline complements previous 
approaches that have been used to elucidate 
mechanisms of chemical toxicity in vitro or 
in vivo by enabling efficient and unbiased 
exploration of chemical-induced transcrip-
tional changes in both types of systems and 
across species. The modules that emerged 
from this analysis suggest that functional 
networks of xenobiotic detoxification 
and response to external stress are highly 
conserved in the hepatic system across human 
and rat. In contrast to pathway conservation, 
our results suggest that the chemicals asso-
ciated with any given module do not show 
a meaningful overlap between in vitro and 
in vivo systems or across species. Although 
this concept seems somewhat counterintui-
tive, it has been observed previously (Zhang 
et al. 2014) and may reflect genuine differ-
ences between systems in chemical bioactiva-
tion through metabolism, thus complicating 
the interpretation of in vivo versus in vitro 
data. Another factor that must be considered 
when assessing the value of our approach is 
the fact that it relied on an expert knowledge–
curated, peer-reviewed database of functional 
pathways. Although the database provided 
an alternative resolution for the orthologous 
gene limitation, we are nevertheless aware 
that annotations in pathway databases are 
incomplete and thus may limit this approach 
to some extent. Some of these limitations 
may be addressed in the future as we extend 
our approach to other systems (e.g., the 
HepG2 hepatocellular carcinoma cell line) 
and to other toxicogenomic databases, such 
as DrugMatrix (Natsoulis et al. 2008), and 
as we integrate more “omics” data, including 
data from RNA sequencing and single nucle-
otide polymorphism profiling, to take into 
account the  variability of individual responses 
to chemicals.
Conclusion
Our analysis of the TG-GATEs data presented 
herein indicates that toxicogenomics-based 
cellular models recapitulate most of the 
pathways related to chemical-induced injury 
in rat liver. Furthermore, it may be possible 
to reduce unnecessary animal testing in 
early toxicological assessments by comple-
menting animal experiments with in vitro 
testing. Because environmental toxicants 
can be associated with alterations in cellular 
pathways that contribute to general injury 
patterns and likely to more severe phenotypes 
such as carcinogenesis, the TGF-βR/SMAD 
module could serve as a putative biomarker 
to identify chemicals with carcinogenic poten-
tial for humans. Notably, potent carcinogenic 
compounds such as 2-acetamidofluorene, 
N-nitrosodiethylamine, and ethanol were 
found in this module in PHH.
Our findings could be generalized to study a 
large set of environmental contaminants relevant 
to human health. Therefore, our method can 
help to identify numerous pathways and genes 
associated with chemical-induced toxicity.
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